| Bioactivity | Syncytial Virus Inhibitor-1 is a potent, orally bioavailable respiratory syncytial virus (RSV) fusion inhibitor with EC50s of 0.002 μM, 0.004 μM, and 0.002 μM for RSV Long, RSV A2, and RSV B strains, respectively[1]. |
| Target | EC50: 0.002 μM (RSV Long), 0.004 μM (RSV A2), 0.002 μM (RSV B) |
| Name | Syncytial Virus Inhibitor-1 |
| CAS | 1422496-79-4 |
| Formula | C23H26N4O3S |
| Molar Mass | 438.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zheng X, et al. Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally BioavailableRespiratory Syncytial Virus Fusion Inhibitors. J Med Chem. 2018 Nov 21;61(22):10228-10241. |
Syncytial Virus Inhibitor-1
CAS: 1422496-79-4 F: C23H26N4O3S W: 438.54
Syncytial Virus Inhibitor-1 is a potent, orally bioavailable respiratory syncytial virus (RSV) fusion inhibitor with EC5
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.